Cotignola J, Roy P, Patel A, et al. Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression

Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Journal of Negative Results in BioMedicine (Impact Factor: 1.47). 02/2007; 6(1):9. DOI: 10.1186/1477-5751-6-9
Source: PubMed


The matrix metalloproteinases (MMPs) are enzymes that cleave various components of the extracellular matrix (ECM) and basement membranes. MMPs are expressed in melanocytes and their overexpression has been linked to tumor development, progression and metastasis. At the genetic level, the following functional promoter polymorphisms are known to modify the gene transcription: -1306 C/T and -735 C/T in the MMP2 gene, and -1171 5A/6A in the MMP3 gene. Functional polymorphisms in MMP genes' promoter regions may modulate the risk for melanoma progression.
We evaluated MMP2 and MMP3 germline polymorphisms in a group of 1002 melanoma patients using PCR-based methods, including fragment size analysis and melting temperature profiles. Two-sided Chi-Square, Cochran-Armitage tests for trend, Fisher's exact tests, and Kendall's Tau tests were performed to evaluate the associations between genotype and various clinical and epidemiologic factors. Multivariate analyses were conducted using logistic regression, adjusting for known melanoma confounders such as age, sex, phenotypic index, moles, freckles, and race. Survival estimates were computed using the Kaplan-Meier method and differences in survival were assessed using the log rank test.
All genotypes were in Hardy-Weinberg equilibrium. After adjustment for age, sex and phenotypic characteristics of melanoma risk, no significant associations were identified with the clinical, pathological, and epidemiological variables studied. The melting profile for MMP2 -735 C/T identified a new change in one sample. A new PCR-amplification followed by direct sequencing confirmed a heterozygote G to A substitution at position -729.
This study does not provide strong evidence for further investigation into the role of the MMP2 and MMP3 variants in melanoma progression.

Download full-text


Available from: Marianne Berwick
  • Source
    • "Functional SNPs in MMP genes promoter regions may modify the production of proteolytic enzymes, and in turn modify the risk for melanoma progression (Cotignola et al., 2007). These proteolytic enzymes are present in normal healthy individuals and up-regulated in almost every type of human cancers. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Matrix metalloproteinases have a range of biological functions, including the liberation of cytokines and membrane-bound receptors, with roles in promotion of tumor invasion and angiogenesis. Several polymorphisms in MMPs have been implicated in the development of cancer as well as other diseases. Since their frequency distributions in the general North Indian population is not known the present study was conducted with the focus on MMP-1(-519) Aandgt; G, MMP-1(-1607) 1Gandgt; 2G, and MMP-7(-181) Aandgt; G gene polymorphisms. PCR-based analysis was conducted for 200 normal healthy individuals of similar ethnicity. Allelic frequencies in wild type of MMP-1(-519) Aandgt; G were 71.2% A; MMP-1(-1607) 1Gandgt; 2G 48.2% 1G; MMP-7(-181) Aandgt; G 60.7% A. The variant allele frequencies were 29% A in MMP-1(-519) Aandgt; G; 52% 2G in MMP-1(-1607) 1Gandgt; 2G; and 39.3% G in MMP-7(-181) Aandgt; G respectively. We further compared frequency distribution for these genes with various published studies in different ethnicity globally. Our results suggest that frequency in these MMP genes exhibit distinctive patterns in India that could perhaps be attributed to ethnic variation. This study is important as it can form a baseline for screening individuals who are at high risk when exposed to environmental carcinogens. More emphasis is needed on evaluating polymorphisms, alone or in combination, as modifiers of risk from relevant environmental/lifestyle exposures.
    Preview · Article · Jan 2009 · Asian Pacific journal of cancer prevention: APJCP
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Describes an approach to the problem of trajectory generation in a workspace by visual servoing. Visual servoing is based on an array of measurements taken from a set of images and used each time as an error function to compute a control vector. This is applied to the system (robot and camera) and enables it to move in order to reach a desired situation, at the end of the task, directly depicted in the image. The originality of this work is based on the concept of a time varying reference feature. Classically, in visual servoing, the reference features are static and the task to be achieved is similar to a positioning task. We define a specific task function which allows us to take into account the time varying aspect and we synthesize a new control law in the sensor space. This control law ensure the trajectory control in the workspace. Considering that any trajectories in workspace can be depicted as a combination of rotation and translation, we have tested our approach using these two elementary trajectories
    Full-text · Conference Paper · Oct 1997
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Matrix metalloproteinases (MMP) degrade various components of the extracellular matrix, and their overexpression has been implicated in tumor progression. Nonsynonymous single nucleotide polymorphisms (SNPs) lead to amino acid substitutions that can alter the function of the encoded protein. We evaluated the associations of six nonsynonymous SNPs in the MMP3, MMP8, and MMP9 genes with skin cancer risk in a nested case-control study of Caucasians within the Nurses' Health Study among 218 melanoma cases, 285 squamous cell carcinoma (SCC) cases, 300 basal cell carcinoma (BCC) cases, and 870 normal controls. We observed that the MMP9 Arg668Gln polymorphism was significantly associated with a decreased risk of SCC. Compared with the Arg/Arg group, the multivariate odds ratio was 0.67 (95% confidence interval, 0.47-0.97) for the Arg/Gln group and 0.21 (95% confidence interval, 0.05-0.97) for the Gln/Gln group (P(trend) = 0.004). We did not observe any association of this SNP with the risks of melanoma and basal cell carcinoma. No associations were found for other SNPs with skin cancer risk. This study provides evidence for the contribution of the MMP9 Arg668Gln to SCC development.
    Preview · Article · Jan 2009 · Cancer Epidemiology Biomarkers & Prevention
Show more